Aimovig
A ‘Paradigm Shift’ for Migraine Prevention
Las Vegas—The FDA approval of erenumab-aooe (Aimovig, Amgen/Novartis) presents a “paradigm shift” ...
JUNE 12, 2018
Aimovig Gets FDA Nod for Migraine Prevention
Aimovig is the first FDA-approved treatment to block the calcitonin gene–related peptide receptor, which ...
MAY 18, 2018
Load more